Skyepharma(SKP)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE Fledgling

Market Cap

£31.59m

Change Today

Price Down-3.50p

Share Price

142.50p

Skyepharma Overview

Skyepharma is a drug research and development company with a leading drug deliveries technology business, specialising in oral, topical, inhalable and injectable delivery systems.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Income & Efficiency

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -37.7% -27.7%
ROCE -43.1%  

Valuation

Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 0.8 0.7
Pr/Book n/a  

Growth

Latest F'cast
Revenue -3.3% 15.3%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Skyepharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-03 a53.15 a(42.98) (4.40)p n/a n/a n/a n/a 0.0%
31-Dec-04 75.20 (18.40) (1.60)p n/a n/a n/a n/a 0.0%
31-Dec-05 50.80 (20.30) (2.50)p n/a n/a n/a n/a 0.0%
31-Dec-06 43.00 (19.30) (3.60)p n/a n/a n/a n/a 0.0%
31-Dec-07 41.60 (23.70) (3.10)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Skyepharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-08 47.97 (13.30) (88.59)p n/a n/a n/a n/a 0.0%
31-Dec-09 48.80 (5.75) (28.97)p n/a n/a n/a n/a 0.0%

Covering analysts: Credit Suisse, Edison Investment Research, Jefferies, Landsbanki Securities

Skyepharma Company Announcements

Statement re Convertible Bonds 03-Oct-2008 11:00 RNS
Holding(s) in Company 02-Oct-2008 08:21 RNS
Holding(s) in Company 01-Oct-2008 17:51 RNS

Skyepharma ShareCast News

London close: Footsie stays ahead 02-Sep-2008 ShareCast
TechMARK movers: Refinancing plan whacks Skyepha... 02-Sep-2008 ShareCast
Friday's newspaper round-up: BoE, Sainsburys, Sk... 29-Aug-2008 ShareCast

Skyepharma Top Newspaper Links

Skyepharma eyes debt swap 13-Jul-2008 Sunday Telegraph
Skyepharma hit by sell-off after collapse of ref... 09-Jul-2008 The Independent
Condella to stand down at Skye 22-May-2008 The Independent

Latest Skyepharma Director Deals

Traded Action Notifier PriceAmountValue
26-Sep-08 Buy Argeris (Jerry) Karabelas 152.00p 3,549 £5,394.48
26-Sep-08 Placing Jean-Charles Tschudin 150.00p 8,578 £12,867.00
26-Sep-08 Placing Alan Bray 150.00p 4,463 £6,694.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Skyepharma Market Data

Currency UK Pounds
Share Price 142.50p Price Down
Change Today -3.50p
52 Week High 1,675.00p
52 Week Low 115.00p
Volume 62,821
Shares Issued 22.17m
Market Cap £31.59m
RiskGrade 907

Skyepharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
97.89% below the market average97.89% below the market average97.89% below the market average97.89% below the market average97.89% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
60.89% below the market average60.89% below the market average60.89% below the market average60.89% below the market average60.89% below the market average
83.1% below the sector average83.1% below the sector average83.1% below the sector average83.1% below the sector average83.1% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 1
Total 2
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Skyepharma Dividends

No dividends found

Trades for 06-Oct-2008

Time Volume / Share Price
16:42 28,500 @ 144.50p
16:38 1,000 @ 142.50p
16:35 984 @ 142.50p
16:24 297 @ 142.50p
16:23 229 @ 142.50p

Skyepharma Key Personnel

CEO Frank Condella
COO Ken Cunningham
Finance Director Peter Grant

Digital Look have been voted
"Best Research and Informataion Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).

A good trader doesn’t blame
his tools…especially ours

The Marketmaker:Investor Edition Trading Tool Kit worth

£765.00!*

Open a spread betting account with
Marketmaker:Investor Edition today and receive

(Or click here to continue with your normal research on Digital Look)

Please remember that spread betting is a leveraged product and carries a high level of risk to your capital. It is possible to incur losses that exceed your initial investment. This product may not be suitable for all investors, therefore ensure you fully understand the risks involved and seek independent advice if necessary.
Digial Look is an Appointed Representative of CMC Spreadbet plc.